Ra­maswamy notch­es his 5th biotech start­up in 3 years af­ter ink­ing a deal with Mer­ck for PhI­II urol­o­gy drug

Vivek Ra­maswamy has launched an­oth­er new biotech com­pa­ny.

Ra­maswamy’s um­brel­la group Roivant Sci­ences notched its 5th “-vant” start­up — Urovant Sci­ences — af­ter bag­ging a Phase III …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER